Skip to main content
Quest Diagnostics

Performance of the Vitek 2, Sensititre, and Etest Antimicrobial Susceptibility Testing Systems for Isolates of Burkholderia cepacia complex

Performance of the Vitek 2, Sensititre, and Etest Antimicrobial Susceptibility Testing Systems for Isolates of Burkholderia cepacia complex

Authors: Shier KL, Gonzales G, Perez DAG, Bao JR, Azad KN

Citation: J Clin Microbiol. 2026 Jan 15:e0048425. doi: 10.1128/jcm.00484-25. Online ahead of print.

Specialties: Infectious disease

Related content

Publication
Increased Odds of Antibiotic Resistance in E. coli Isolates from Recurrent Urinary Tract Infections
Publication
First Description of the Performance of the VITEK MITUBE Device Used With MALDI-TOF Mass Spectrometry to Achieve Identification of Gram-Negative Bacteria Directly From Positive Blood Culture Broth
Audio Podcast
Growing as a Laboratory Partner
Conference Presentation
Rapid Antimicrobial Susceptibility Testing (rAST) Directly from Positive Blood Cultures, A Pilot Study on ASTar Platform (Q-Linea)
Test FAQ
Cystic Fibrosis Screen
Test FAQ
CFvantage Cystic Fibrosis Expanded Screen

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.